임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
48건 표시
- 3상모집 중· Hidradenitis SuppurativaAn Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS
리드: 노바티스
- 3상모집 중· Primary Myelofibrosis (PMF)A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
리드: 노바티스
- 3상모집 중· Progressive Supranuclear Palsy Richardson Syndrome (PSP-RS)A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy
리드: 노바티스
- 3상모집 중· Cardiovascular Disease and Lipoprotein(a)An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
리드: 노바티스
- 3상모집 중· Indication of the Parent ProtocolRemibrutinib Open Label Roll-over Post-trial Access Protocol
리드: 노바티스
- 3상모집 중· Huntington DiseaseA Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease
리드: 노바티스
- 3상모집 중· Primary Immunoglobulin A Nephropathy (IgAN)Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN
리드: 노바티스
- 3상모집 중· Secondary Progressive Multiple Sclerosis (SPMS)A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
리드: 노바티스
- 3상모집 중· Paroxysmal Nocturnal Hemoglobinuria (PNH)Study to Assess the Pharmacokinetics, Safety, and Tolerability of Iptacopan in Pediatric PNH Patients
리드: 노바티스
- 3상모집 중· Acute Coronary SyndromeEvaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronary Syndromes
리드: 노바티스
- 3상모집 중· Kidney DiseasesOpen-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
리드: 노바티스
- 3상모집 중· Prostate CancerStudy Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
리드: 노바티스
- 3상모집 중· Relapsing Multiple SclerosisEfficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
리드: 노바티스
- 3상모집 중· Somatostatin Receptor Positive (SSTR+)Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
리드: 노바티스
- 3상모집 중· Atherosclerotic Cardiovascular Disease (ASCVD)Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
리드: 노바티스
- 3상모집 중· Familial Hypercholesterolemia - HomozygousStudy to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia
리드: 노바티스
- 3상모집 중· Generalized Myasthenia GravisA Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis
리드: 노바티스
- 3상모집 중· Familial Hypercholesterolemia - HeterozygousStudy to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
리드: 노바티스
- 3상모집 중· Prostate Cancer MetastaticStandard of Care +/- 177Lu-PSMA-617 In de Novo mHSPC Patients With Poor PSA Response (PEACE6-Poor Responders)
협력: 노바티스
- 3상모집 중· Hematologic MalignancyAn Extension Study for Patients Previously Enrolled in Studies With Pelabresib
리드: 노바티스
- 3상모집 중· Generalized Myasthenia GravisA Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 85 Years With gMG.
리드: 노바티스
- 3상모집 중· Prostate Cancer MetastaticA Randomised Controlled Platform Trial Testing Treatments in Metastatic Hormone Sensitive Prostate Cancer
협력: 노바티스
- 3상모집 중· Systemic Lupus ErythematosusPhase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
리드: 노바티스
- 3상모집 중· Atypical Hemolytic Uremic SyndromeEvaluate Long-term Safety, Tolerability and Efficacy of Iptacopan in Study Participants With aHUS
리드: 노바티스
- 3상모집 중· Oligometastatic Prostate Cancer (OMPC)An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
리드: 노바티스
- 3상모집 중· Atypical Hemolytic Uremic SyndromeEfficacy and Safety of Switching From Anti-C5 Antibody Treatment to Iptacopan Treatment in Study Participants With Atypical Hemolytic Uremic Syndrome (aHUS)
리드: 노바티스
- 3상모집 중· Sickle Cell Anemia in ChildrenPromoting Utilization and Safety of Hydroxyurea Using Precision in Africa
협력: 노바티스
- 3상모집 중· Chronic Spontaneous Urticaria24 Weeks Double-blind Randomized Placebo-controlled Trial to Evaluate Efficacy, PK, Safety of LOU064 in Adolescents (12 - <18) With CSU and Inadequate Response to H1-antihistamine Followed by Optional 3 Years Open-label Extension and an Optional 3 Years Safety Long-term Treatment-free Follow-up
리드: 노바티스
- 3상모집 중· Heterozygous or Homozygous Familial HypercholesterolemiaLong-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 Studies
리드: 노바티스
- 3상모집 중· Ovarian Neoplasm EpithelialMAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO)
협력: 노바티스, 로슈
- 3상모집 중· B-cell Acute Lymphoblastic LeukemiaStudy of Out of Specification for Tisagenlecleucel
리드: 노바티스
- 3상모집 중· Polycythemia VeraMITHRIDATE: Ruxolitinib Versus Hydroxycarbamide or Interferon as First Line Therapy in High Risk Polycythemia Vera
협력: 노바티스
- 3상모집 중· C3 GlomerulopathyLong-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN
리드: 노바티스
- 3상모집 중· Non-metastatic Soft-tissue SarcomaBenefit of Intensified Peri-operative Chemotherapy Within High-risk CINSARC Patients With Resectable Soft-tissue Sarcomas
협력: 노바티스
- 3상모집 중· Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access ProgramCAR-T Long Term Follow Up (LTFU) Study
리드: 노바티스
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.